Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumors
Elizabeth Fox(University of Pennsylvania), Brigitte C. Widemann(National Cancer Institute), Devang Pastakia(Vanderbilt University), Clara C. Chen(National Institutes of Health Clinical Center), Sherry Yang(National Cancer Institute), Diane E. Cole(National Cancer Institute), Frank M. Balis(University of Pennsylvania)
Cited by 68Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis